THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Mark Huycke to Anti-Bacterial Agents

This is a "connection" page, showing publications Mark Huycke has written about Anti-Bacterial Agents.
Connection Strength

0.312
  1. Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream. Sci Transl Med. 2019 04 10; 11(487).
    View in: PubMed
    Score: 0.117
  2. Transfer of pheromone-inducible plasmids between Enterococcus faecalis in the Syrian hamster gastrointestinal tract. J Infect Dis. 1992 Nov; 166(5):1188-91.
    View in: PubMed
    Score: 0.075
  3. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium. Clin Infect Dis. 1998 Nov; 27(5):1278-85.
    View in: PubMed
    Score: 0.028
  4. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis. 1998 Apr-Jun; 4(2):239-49.
    View in: PubMed
    Score: 0.027
  5. Surgical Infection Society position on vancomycin-resistant Enterococcus. Arch Surg. 1996 Oct; 131(10):1061-8.
    View in: PubMed
    Score: 0.025
  6. Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice. J Infect Dis. 1995 Jul; 172(1):273-6.
    View in: PubMed
    Score: 0.023
  7. Enterococcus: an old pathogen with new tricks. J Okla State Med Assoc. 1991 Jul; 84(7):305-9.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES